Articles with "post hct" as a keyword



Photo from wikipedia

Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Clinical Immunology"

DOI: 10.1007/s10875-022-01261-1

Abstract: Granulocyte transfusions are sometimes used as adjunctive therapy for the treatment of infection in patients with chronic granulomatous disease (CGD). However, granulocyte transfusions can be associated with a high rate of alloimmunization, and their role… read more here.

Keywords: therapy; patients chronic; granulocyte transfusions; chronic granulomatous ... See more keywords
Photo from wikipedia

Measuring Patient-Reported Outcomes (PROs) in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients

Sign Up to like & get
recommendations!
Published in 2020 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2019.12.236

Abstract: PROs are increasingly used in HCT to capture symptoms, quality of life, and functional status. At the Cleveland Clinic, PROs are systematically collected prior to ambulatory visits and used in routine clinical care to identify… read more here.

Keywords: time; hct; post hct; pre hct ... See more keywords
Photo from wikipedia

Burden of Vaccine-Preventable Infections Among Pediatric Hematopoietic Cell Transplant Recipients

Sign Up to like & get
recommendations!
Published in 2020 at "Biology of Blood and Marrow Transplantation"

DOI: 10.1016/j.bbmt.2019.12.367

Abstract: Background Hematopoietic cell transplantation (HCT) recipients are increased risk for vaccine-preventable infections (VPI). However, the true prevalence of VPI in children post-HCT is unknown. Methods We performed an epidemiological study using the Pediatric Health Information… read more here.

Keywords: vaccine preventable; preventable infections; vpi; hematopoietic cell ... See more keywords
Photo by nci from unsplash

Recommendations for reporting post-transplant relapse in AML

Sign Up to like & get
recommendations!
Published in 2018 at "Bone Marrow Transplantation"

DOI: 10.1038/bmt.2017.227

Abstract: Relapse continues to be the primary cause of death after allogeneic hematopoietic cell transplantation (allo-HCT) in patients with AML. Our current sophisticated molecular and genomic techniques have enabled us to deeply explore the clearance, persistence… read more here.

Keywords: relapse; post hct; relapse aml; post ... See more keywords
Photo from wikipedia

Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation

Sign Up to like & get
recommendations!
Published in 2022 at "JCO Clinical Cancer Informatics"

DOI: 10.1200/cci.21.00156

Abstract: PURPOSE Allogenic hematopoietic stem-cell transplant (HCT) is a curative therapy for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Relapse post-HCT is the most common cause of treatment failure and is associated with a poor… read more here.

Keywords: post hct; hct; relapse; texture ... See more keywords
Photo by papaioannou_kostas from unsplash

Distinct Clinical Manifestations of Thyroid Cancer After Hematopoietic Stem Cell Transplantation

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Surgical Oncology"

DOI: 10.1245/s10434-019-07442-4

Abstract: BackgroundThe incidence of a secondary solid malignancy after hematopoietic cell transplantation (HCT) is increasing in long-term survivors.ObjectiveThe aim of this study was to compare the clinicopathological characteristics of HCT recipients with secondary thyroid cancer (STC),… read more here.

Keywords: hct group; group; thyroid cancer; post hct ... See more keywords
Photo from wikipedia

Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.966301

Abstract: The age of allogeneic hematopoietic cell transplant (HCT) donors and their hematopoietic cell telomere length (TL) might affect recipients’ outcomes. Our goals were to examine the possible effect of these donors’ factors on the recipients’… read more here.

Keywords: cell; hematopoietic cell; post hct; age ... See more keywords